Primerica (PRI) Projected to Post Earnings on Wednesday

Primerica (NYSE:PRI - Get Free Report) is expected to be issuing its Q1 2025 quarterly earnings data after the market closes on Wednesday, May 7th. Analysts expect Primerica to post earnings of $4.77 per share and revenue of $783.54 million for the quarter.

Primerica (NYSE:PRI - Get Free Report) last issued its quarterly earnings data on Tuesday, February 11th. The financial services provider reported $5.03 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $4.81 by $0.22. Primerica had a return on equity of 31.11% and a net margin of 15.14%. On average, analysts expect Primerica to post $21 EPS for the current fiscal year and $23 EPS for the next fiscal year.

Primerica Trading Down 0.2 %

PRI stock traded down $0.43 during trading on Monday, hitting $265.59. The company had a trading volume of 22,819 shares, compared to its average volume of 169,462. The stock has a market cap of $8.79 billion, a PE ratio of 19.32 and a beta of 1.02. The business has a 50-day moving average of $271.54 and a 200-day moving average of $280.56. Primerica has a one year low of $211.54 and a one year high of $307.91.

Primerica Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Friday, February 21st were paid a $1.04 dividend. This is a positive change from Primerica's previous quarterly dividend of $0.90. This represents a $4.16 dividend on an annualized basis and a dividend yield of 1.57%. The ex-dividend date of this dividend was Friday, February 21st. Primerica's dividend payout ratio is currently 30.25%.

Insider Buying and Selling

In other news, insider Nicholas Adam Jendusa sold 234 shares of the stock in a transaction that occurred on Wednesday, March 5th. The stock was sold at an average price of $280.15, for a total value of $65,555.10. Following the completion of the sale, the insider now directly owns 200 shares of the company's stock, valued at $56,030. This represents a 53.92 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, President Peter W. Schneider sold 2,000 shares of the firm's stock in a transaction that occurred on Wednesday, March 5th. The shares were sold at an average price of $282.90, for a total value of $565,800.00. Following the completion of the transaction, the president now owns 13,301 shares in the company, valued at $3,762,852.90. This represents a 13.07 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 5,234 shares of company stock worth $1,476,575 in the last ninety days. Corporate insiders own 0.61% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on the stock. Morgan Stanley dropped their target price on shares of Primerica from $313.00 to $304.00 and set an "equal weight" rating on the stock in a report on Friday, February 28th. StockNews.com downgraded Primerica from a "buy" rating to a "hold" rating in a research note on Friday, February 7th. Keefe, Bruyette & Woods decreased their target price on Primerica from $320.00 to $315.00 and set a "market perform" rating for the company in a research note on Wednesday, April 9th. Finally, BMO Capital Markets initiated coverage on Primerica in a research note on Thursday, January 23rd. They issued a "market perform" rating and a $311.00 price target on the stock. Six investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, the stock has an average rating of "Hold" and an average target price of $309.14.

Primerica Company Profile

Primerica, Inc, together with its subsidiaries, provides financial products and services to middle-income households in the United States and Canada. The company operates in four segments: Term Life Insurance; Investment and Savings Products; Senior Health; and Corporate and Other Distributed Products.